About Sensus Healthcare (NASDAQ:SRTS)
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SRTS
CUSIPN/A
Phone561-922-5808
Debt
Debt-to-Equity Ratio0.19%
Current Ratio3.68%
Quick Ratio3.44%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$20.59 million
Price / Sales3.86
Cash FlowN/A
Price / CashN/A
Book Value$0.87 per share
Price / Book6.75
Profitability
EPS (Most Recent Fiscal Year)($0.28)
Net Income$-3,710,000.00
Net Margins-18.02%
Return on Equity-29.60%
Return on Assets-19.83%
Miscellaneous
Employees45
Outstanding Shares13,540,000
Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions
What is Sensus Healthcare's stock symbol?
Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."
How were Sensus Healthcare's earnings last quarter?
Sensus Healthcare (NASDAQ:SRTS) announced its quarterly earnings data on Thursday, February, 1st. The company reported ($0.03) EPS for the quarter, topping the Zacks' consensus estimate of ($0.08) by $0.05. The business earned $6.47 million during the quarter, compared to the consensus estimate of $5.95 million. Sensus Healthcare had a negative return on equity of 29.60% and a negative net margin of 18.02%. View Sensus Healthcare's Earnings History.
What price target have analysts set for SRTS?
1 brokerages have issued 12 month target prices for Sensus Healthcare's stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate Sensus Healthcare's stock price to reach $9.00 in the next twelve months. View Analyst Ratings for Sensus Healthcare.
Who are some of Sensus Healthcare's key competitors?
Some companies that are related to Sensus Healthcare include Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), T2 Biosystems (TTOO), Orthopediatrics (KIDS), Cytosorbents (CTSO), Nuvectra (NVTR), IRadimed (IRMD), SeaSpine (SPNE), Restoration Robotics (HAIR), Alphatec (ATEC), Apollo Endosurgery (APEN), INVO Bioscience (IVOB), Invuity (IVTY), Motus GI (MOTS) and Obalon Therapeutics (OBLN).
Who are Sensus Healthcare's key executives?
Sensus Healthcare's management team includes the folowing people:
- Mr. Joseph C. Sardano, Chairman, CEO & Pres (Age 65)
- Mr. Arthur R. Levine, CFO & Principal Accounting Officer
- Mr. Stephen Cohen, Exec. VP of Dermatology Sales & Marketing (Age 58)
- Mr. Kalman Fishman, Chief Operating Officer and Chief Technology Officer (Age 47)
- Michael Sardano, Gen. Counsel and Corp. Sec.
When did Sensus Healthcare IPO?
(SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.
Has Sensus Healthcare been receiving favorable news coverage?
News coverage about SRTS stock has trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sensus Healthcare earned a daily sentiment score of 0.11 on Accern's scale. They also gave media headlines about the company an impact score of 47.45 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Sensus Healthcare?
Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sensus Healthcare's stock price today?
One share of SRTS stock can currently be purchased for approximately $5.87.
How big of a company is Sensus Healthcare?
Sensus Healthcare has a market capitalization of $81.91 million and generates $20.59 million in revenue each year. The company earns $-3,710,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. Sensus Healthcare employs 45 workers across the globe.
How can I contact Sensus Healthcare?
Sensus Healthcare's mailing address is 851 BROKEN SOUND PKWY. NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]
MarketBeat Community Rating for Sensus Healthcare (SRTS)
MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote "Outperform" if you believe SRTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sensus Healthcare (NASDAQ:SRTS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Sensus Healthcare in the last 12 months. Their average twelve-month price target is $9.00, suggesting that the stock has a possible upside of 53.32%. The high price target for SRTS is $9.00 and the low price target for SRTS is $9.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $9.00 | $9.00 | $7.50 | $6.50 |
| Price Target Upside: | 53.32% upside | 63.64% upside | 28.21% upside | 62.50% upside |
Sensus Healthcare (NASDAQ:SRTS) Consensus Price Target History
Sensus Healthcare (NASDAQ:SRTS) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 2/2/2018 | Maxim Group | Boost Price Target | Buy -> Buy | $7.50 -> $9.00 | Medium |  |
| 8/8/2016 | Northland Securities | Reiterated Rating | Outperform | $8.00 | N/A | |
(Data available from 4/27/2016 forward)
Sensus Healthcare (NASDAQ:SRTS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Sensus Healthcare (NASDAQ SRTS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 41.70%
Institutional Ownership Percentage: 6.20%
Sensus Healthcare (NASDAQ SRTS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/27/2017 | Arthur Levine | CFO | Sell | 217 | $6.00 | $1,302.00 | 216,793 | |
| 10/27/2017 | Joseph C Sardano | CEO | Sell | 6,953 | $6.00 | $41,718.00 | 1,587,701 | |
| 10/27/2017 | Kalman Fishman | Insider | Sell | 4,183 | $6.00 | $25,098.00 | 960,649 | |
| 9/12/2017 | Arthur Levine | CFO | Sell | 381 | $6.00 | $2,286.00 | 217,357 | |
| 9/12/2017 | Joseph C Sardano | CEO | Sell | 12,192 | $6.00 | $73,152.00 | 1,605,751 | |
| 9/12/2017 | Richard Golin | Insider | Sell | 7,334 | $6.00 | $44,004.00 | 971,509 | |
| 9/6/2017 | Arthur Levine | CFO | Sell | 417 | $6.00 | $2,502.00 | 217,618 | |
| 9/6/2017 | Joseph C Sardano | CEO | Sell | 13,320 | $6.00 | $79,920.00 | 1,614,099 | |
| 9/6/2017 | Kalman Fishman | CTO | Sell | 2,250 | $6.00 | $13,500.00 | 976,530 | |
| 9/6/2017 | Richard Golin | Insider | Sell | 8,012 | $6.00 | $48,072.00 | 976,530 | |
| 9/5/2017 | Arthur Levine | CFO | Sell | 300 | $6.00 | $1,800.00 | 217,618 | |
| 9/5/2017 | Joseph C Sardano | CEO | Sell | 9,579 | $6.00 | $57,474.00 | 1,614,099 | |
| 9/5/2017 | Kalman Fishman | CTO | Sell | 5,762 | $6.00 | $34,572.00 | 976,530 | |
| 8/28/2017 | Arthur Levine | CFO | Sell | 302 | $6.00 | $1,812.00 | 217,985 | |
| 8/28/2017 | Joseph C Sardano | CEO | Sell | 9,625 | $6.00 | $57,750.00 | 1,625,821 | |
| 8/28/2017 | Stephen Brad Cohen | Insider | Sell | 3,908 | $6.00 | $23,448.00 | 983,583 | |
| 8/24/2017 | Arthur Levine | CFO | Sell | 271 | $6.00 | $1,626.00 | 218,220 | |
| 8/24/2017 | Joseph C Sardano | CEO | Sell | 8,167 | $6.00 | $49,002.00 | 1,637,891 | |
| 8/24/2017 | Kalman Fishman | Insider | Sell | 5,378 | $6.00 | $32,268.00 | 990,845 | |
| 12/2/2016 | Joseph C Sardano | CEO | Sell | 274 | $6.00 | $1,644.00 | 1,641,636 | |
| 12/2/2016 | Richard Golin | Insider | Sell | 187 | $6.00 | $1,122.00 | 993,586 | |
| 11/30/2016 | Joseph C Sardano | CEO | Sell | 924 | $6.00 | $5,544.00 | 1,642,264 | |
| 11/30/2016 | Stephen Brad Cohen | Insider | Sell | 679 | $6.00 | $4,074.00 | 994,032 | |
(Data available from 1/1/2013 forward)
Sensus Healthcare (NASDAQ SRTS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018
finance.yahoo.com - April 26 at 9:28 AM |
| Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments
finance.yahoo.com - April 19 at 9:43 AM |
| Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
finance.yahoo.com - March 8 at 10:06 AM |
| Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions
finance.yahoo.com - March 5 at 9:59 AM |
| Sensus Healthcare Inc (SRTSU) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 16 at 9:18 AM |
| Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe
finance.yahoo.com - February 7 at 9:03 AM |
| Blog Exposure - Teleflex Announces Launch of Expro Elite(TM) and Sympro Elite(TM) Snares for Peripheral Procedures in the US
finance.yahoo.com - February 7 at 9:03 AM |
 | Active-Investors: Free Research Report as Hill-Rom's Revenue Rose 5% and Adjusted EPS Surged 23%
www.finanznachrichten.de - February 6 at 4:33 PM |
| Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World
finance.yahoo.com - February 5 at 8:59 AM |
 | Maxim Group Boosts Sensus Healthcare (SRTS) Price Target to $9.00
www.americanbankingnews.com - February 2 at 5:06 PM |
| Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year
finance.yahoo.com - February 1 at 4:35 PM |
| Sensus Healthcare, Inc. to Host Earnings Call
finance.yahoo.com - February 1 at 4:35 PM |
| Sensus Healthcare (SRTS) Downgraded by TheStreet
www.americanbankingnews.com - January 30 at 7:32 AM |
| Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018
finance.yahoo.com - January 25 at 8:59 AM |
 | Sensus Healthcare Brings Superficial Radiation Therapy (SRT) to China for Keloid Prevention and Treatment
www.bizjournals.com - January 8 at 9:36 AM |
| Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017
finance.yahoo.com - November 30 at 11:25 AM |
| Sensus Healthcare to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - November 27 at 4:10 PM |
 | Sensus Healthcare beats by $0.02, beats on revenue
seekingalpha.com - November 4 at 10:34 PM |
| Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%
finance.yahoo.com - November 4 at 5:28 PM |
| Edited Transcript of SRTS earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 4 at 5:28 PM |
| Sensus Healthcare, Inc. (SRTS) Price Target Raised to $7.50 at Maxim Group
www.americanbankingnews.com - November 3 at 8:52 AM |
| Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
finance.yahoo.com - November 1 at 9:09 AM |
| Sensus Healthcare, Inc. (SRTS) Insider Sells $25,098.00 in Stock
www.americanbankingnews.com - October 31 at 2:51 PM |
| Insider Selling: Sensus Healthcare, Inc. (SRTS) CEO Sells 6,953 Shares of Stock
www.americanbankingnews.com - October 31 at 2:38 PM |
| Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico
finance.yahoo.com - October 31 at 9:58 AM |
| Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017
finance.yahoo.com - October 25 at 11:10 AM |
| Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care
finance.yahoo.com - October 24 at 10:26 AM |
| Sensus Healthcare (SRTS) Presents At 3rd Annual Dawson James Small Cap Growth Conference 2017 - lideshow
seekingalpha.com - October 21 at 8:49 AM |
| Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
finance.yahoo.com - October 11 at 8:03 AM |
| Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
finance.yahoo.com - October 10 at 7:06 AM |
| Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
finance.yahoo.com - October 10 at 7:06 AM |
| Sensus Healthcare (SRTS) Presents At The Sidoti & Company Fall 2017 Convention - Slideshow
seekingalpha.com - September 30 at 7:56 PM |
| Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 20 at 9:25 AM |
| Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 8:00 AM |
| Insider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 7,334 Shares of Stock
www.americanbankingnews.com - September 13 at 4:36 PM |
| Sensus Healthcare, Inc. (SRTS) CEO Joseph C. Sardano Sells 12,192 Shares
www.americanbankingnews.com - September 13 at 4:34 PM |
| Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma
finance.yahoo.com - September 12 at 10:14 AM |
| Kalman Fishman Sells 5,762 Shares of Sensus Healthcare Inc (SRTS) Stock
www.americanbankingnews.com - September 6 at 10:46 PM |
| Sensus Healthcare Inc (SRTS) CTO Sells $13,500.00 in Stock
www.americanbankingnews.com - September 6 at 10:46 PM |
| Sensus Healthcare Inc (SRTS) Insider Richard Golin Sells 8,012 Shares
www.americanbankingnews.com - September 6 at 10:26 PM |
| Sensus Healthcare Inc (SRTS) CEO Sells $57,474.00 in Stock
www.americanbankingnews.com - September 6 at 10:26 PM |
| Joseph C. Sardano Sells 13,320 Shares of Sensus Healthcare Inc (SRTS) Stock
www.americanbankingnews.com - September 6 at 10:26 PM |
| Sensus Healthcare to Present at Upcoming Investor Conferences
finance.yahoo.com - September 6 at 8:35 AM |
| Stephen Brad Cohen Sells 3,908 Shares of Sensus Healthcare, Inc. (SRTS) Stock
www.americanbankingnews.com - August 29 at 4:16 PM |
| Sensus Healthcare, Inc. (SRTS) CEO Sells $57,750.00 in Stock
www.americanbankingnews.com - August 29 at 4:16 PM |
| Insider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 5,378 Shares of Stock
www.americanbankingnews.com - August 25 at 4:32 PM |
| Joseph C. Sardano Sells 8,167 Shares of Sensus Healthcare, Inc. (SRTS) Stock
www.americanbankingnews.com - August 25 at 4:32 PM |
| Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 24 at 1:18 PM |
| Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer
finance.yahoo.com - August 11 at 8:48 AM |
| Edited Transcript of SRTS earnings conference call or presentation 3-Aug-17 8:30pm GMT
finance.yahoo.com - August 5 at 7:20 AM |
Sensus Healthcare (NASDAQ:SRTS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Sensus Healthcare (NASDAQ:SRTS) Income Statement, Balance Sheet and Cash Flow Statement
Sensus Healthcare (NASDAQ SRTS) Stock Chart for Friday, April, 27, 2018
Loading chart…
